This protocol is judged by an institutional overview board, an independent group that testimonials any medical trials involving humans. If a analyze entails a Schedule I drug, once the board approves the protocol as ethical, the researchers really need to submit an application for an investigational new drug (IND) number with the FDA.Access to unl